FDA Adverse Event Injury Summary report: N

XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2760658 · Received September 26, 2012

Report

Report Number
2024168-2012-06064
Event Type
Injury
Date Received
September 26, 2012
Date of Event
September 4, 2012
Report Date
September 4, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY AND THE PRODUCT WAS NOT RETURNED. THE REPORTED PATIENT EFFECTS OF ANGINA AND THROMBOSIS, AS LISTED IN THE XIENCE PRIME INSTRUCTIONS FOR USE, ARE KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 1 MONTH POST XIENCE PRIME STENT IMPLANTATION IN THE CIRCUMFLEX, PLAVIX WAS DISCONTINUED BECAUSE OF A PLANNED UNRELATED SURGICAL PROCEDURE. ON (B)(6) 2012, THE PATIENT WAS HOSPITALIZED FOR THE URELATED PLANNED SURGERY. WHILE HOSPITALIZED, THE PATIENT EXPERIENCED ANGINA. ON (B)(6) 2012, DURING A DIAGNOSTIC ANGIOGRAPHY, STENT THROMBOSIS WAS FOUND IN THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY. THE THROMBUS WAS SUCTIONED AND ANGIOPLASTY WAS PERFORMED. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 111104Q

Patients

Seq Age Sex Outcome Treatment
1 84 YR Hospitalization| R